WO2001028590A3 - PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER Download PDFInfo
- Publication number
- WO2001028590A3 WO2001028590A3 PCT/US2000/028731 US0028731W WO0128590A3 WO 2001028590 A3 WO2001028590 A3 WO 2001028590A3 US 0028731 W US0028731 W US 0028731W WO 0128590 A3 WO0128590 A3 WO 0128590A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aspartyl
- dimethylbutyl
- pharmaceutical compositions
- methyl ester
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004384 Neotame Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 abstract 1
- 235000019412 neotame Nutrition 0.000 abstract 1
- 108010070257 neotame Proteins 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
- A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Seasonings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU10934/01A AU1093401A (en) | 1999-10-19 | 2000-10-18 | Pharmaceutical compositions containing n-(n-(3,3-dimethylbutyl)-1-alpha-aspartyl)-l-phenylalanine methyl ester |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16030599P | 1999-10-19 | 1999-10-19 | |
US60/160,305 | 1999-10-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001028590A2 WO2001028590A2 (en) | 2001-04-26 |
WO2001028590A3 true WO2001028590A3 (en) | 2008-01-03 |
Family
ID=22576354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/028731 WO2001028590A2 (en) | 1999-10-19 | 2000-10-18 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1093401A (en) |
WO (1) | WO2001028590A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2859603B1 (en) * | 2003-09-11 | 2005-12-30 | Christian Fenioux | USE OF NEOHESPERIDINE DIHYDROCHALCONE IN ORAL COMPOSITIONS COMPRISING VITAMINS AND / OR MINERALS |
JP5852783B2 (en) * | 2011-02-25 | 2016-02-03 | 小川香料株式会社 | Taste improver for high-intensity sweeteners |
GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0866073A1 (en) * | 1997-03-18 | 1998-09-23 | Ajinomoto Co., Ltd. | Novel dipeptide derivatives and sweetening agents |
WO1999012957A1 (en) * | 1997-09-11 | 1999-03-18 | The Nutrasweet Company | BASIC SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER |
WO1999030576A1 (en) * | 1997-12-17 | 1999-06-24 | The Nutrasweet Company | Beverage compositions comprising sweetener with extremely high potency |
JPH11279081A (en) * | 1998-03-27 | 1999-10-12 | Ajinomoto Co Inc | Composition containing bitter material |
WO1999057998A1 (en) * | 1998-05-08 | 1999-11-18 | Ajinomoto Co., Inc. | Novel sweetener compositions |
WO1999062354A1 (en) * | 1998-06-05 | 1999-12-09 | Wm. Wrigley Jr. Company | Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby |
WO2000036933A1 (en) * | 1998-12-18 | 2000-06-29 | The Nutrasweet Company | USE OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER AS A FLAVOR MODIFIER |
WO2000057726A1 (en) * | 1999-03-29 | 2000-10-05 | The Nutrasweet Company | NUTRACEUTICALS HAVING N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
-
2000
- 2000-10-18 WO PCT/US2000/028731 patent/WO2001028590A2/en active Application Filing
- 2000-10-18 AU AU10934/01A patent/AU1093401A/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0866073A1 (en) * | 1997-03-18 | 1998-09-23 | Ajinomoto Co., Ltd. | Novel dipeptide derivatives and sweetening agents |
WO1999012957A1 (en) * | 1997-09-11 | 1999-03-18 | The Nutrasweet Company | BASIC SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER |
WO1999030576A1 (en) * | 1997-12-17 | 1999-06-24 | The Nutrasweet Company | Beverage compositions comprising sweetener with extremely high potency |
JPH11279081A (en) * | 1998-03-27 | 1999-10-12 | Ajinomoto Co Inc | Composition containing bitter material |
WO1999057998A1 (en) * | 1998-05-08 | 1999-11-18 | Ajinomoto Co., Inc. | Novel sweetener compositions |
JPH11318381A (en) * | 1998-05-08 | 1999-11-24 | Ajinomoto Co Inc | New sweetener composition |
WO1999062354A1 (en) * | 1998-06-05 | 1999-12-09 | Wm. Wrigley Jr. Company | Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby |
WO2000036933A1 (en) * | 1998-12-18 | 2000-06-29 | The Nutrasweet Company | USE OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER AS A FLAVOR MODIFIER |
WO2000057726A1 (en) * | 1999-03-29 | 2000-10-05 | The Nutrasweet Company | NUTRACEUTICALS HAVING N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 200006, Derwent World Patents Index; AN 2000-053011 * |
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 1 31 January 2000 (2000-01-31) * |
Also Published As
Publication number | Publication date |
---|---|
WO2001028590A2 (en) | 2001-04-26 |
AU1093401A (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3680300A (en) | Sucralose-containing composition and eatable product comprising the same | |
HUP9902138A3 (en) | N-[4-(heteroarylmethyl)phenyl]-heteroarylamine derivatives, their preparation and pharmaceutical compositions containing them | |
AU5397699A (en) | Pasteurized or ultra-pasteurized complete nutritional compositions and products | |
ATE307492T1 (en) | FLAVOR-MODIFIED FLAVOR PRODUCTS CONTAINING ACTIVE INGREDIENTS | |
AU6608000A (en) | Soy products having improved odor and flavor and methods related thereto | |
IL150539A0 (en) | Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them | |
HUP0004400A3 (en) | Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
MY120984A (en) | Activated protein c formulations | |
EP1529776A3 (en) | Amino acid derivatives and sweetening agent | |
AU7363600A (en) | Breath freshening comestible product | |
HUP0100669A3 (en) | Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof | |
AU2417100A (en) | N-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester synergistic sweetener blends | |
AU2001235737A1 (en) | Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same | |
WO2001090138A3 (en) | SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING OXAZOLIDINONE DERIVATIVES | |
AU2002232667A1 (en) | Food preparation aroma system for dehydrated food product compositions | |
PL363242A1 (en) | Food preparation aroma system for dehydratid food product compositions | |
WO1998019697A3 (en) | Novel pharmaceutical compositions | |
HUP0003734A2 (en) | Salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester, sweetener compositions containing them | |
BR0005332A (en) | Encapsulated aroma | |
WO2001028590A3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER | |
AU6238800A (en) | Confectionery food products sweetened with n-[n-(3,3-dimethylbutyl)-1-alpha-aspartyl]-l-phenylalanine methyl ester | |
AU2683700A (en) | Flavour/aroma materials and their preparation | |
AU1094301A (en) | Personal care products using n-(n-(3,3-dimethylbutyl)-1-alpha-aspartyl)-l-phenylalanine methyl ester | |
WO2000052019A3 (en) | Crystallization products of neotame and methods for producing same | |
AU4644299A (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosisand treatment of anti-phospholipid syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |